Hemophilia B
6 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| CSL222 (AAV5-hFIXco-Padua) for hemophilia b | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua) for hemophilia b | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fidanacogene Elaparvovec for hemophilia b | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Fitusiran for hemophilia b | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Marstacimab for hemophilia b | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SR604 for hemophilia b | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |